Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The last time a CEO quote was omitted and the BOD was included????

There are at least 73 licensees who paid a combined $293M who would contradict your point about being ready.

Additionally, PTSC is a public company and it is dependent on the BOD and Management decisions for EVERYTHING it does. The buck stops there. While you can excuse the USPTO issues as beyond their control, IMO, you CAN'T excuse the BOD and Management from performing just because of the re-exams.

The questions from without and within that I refer to come from TPL/PTSC conflicts, TPL/Moore conflicts, BOD/CEO conflicts, PTSC/Acquisition target conflicts, questionable financial strategies, poor communication strategies, questionable severance deals, etc., that have NOTHING to do with the USPTO, but that have led to a company that is viewed as poorly directed, poorly managed, and despite revenues averaging nearly $30M per year against relatively little expense, a poor risk by shareholders and the market in general.

You imply that the BOD and the CEO's should only be judged under ideal business environments, when the truth is those who are judged favorably are judged so because of their ability to navigate and manage to prosper even when there are choppy waters.

In the words of Dana Carvey doing his Ross Perot impression, even a monkey could manage 5% growth! lol

Share
New Message
Please login to post a reply